Resveratrol ameliorates high glucose and high-fat/sucrose diet-induced vascular hyperpermeability involving Cav-1/eNOS regulation

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Peng, Xiao Lin ^a,b   Qu, Wei ^c   Wang, Lin Zhi ^a,d   Huang, Bin Qing ^a,d   Ying, Chen Jiang ^a,d   Sun, Xiu Fa ^a,d   Hao, Li Ping ^a,d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Shenzhen Nanshan Center for Chronic Disease Control   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FAT; GLUCOSE; N(G) NITROARGININE METHYL ESTER; RESVERATROL; SUCROSE; ANGIOGENESIS INHIBITOR; CARBOHYDRATE DIET; FAT INTAKE; STILBENE DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; ENZYME PHOSPHORYLATION; GLUCOSE INTAKE; IN VITRO STUDY; LIPID DIET; MALE; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIAL HYPERPERMEABILITY; ADMINISTRATION AND DOSAGE; ANIMAL; BOVINE; CAPILLARY PERMEABILITY; CARBOHYDRATE DIET; CELL CULTURE; DRUG EFFECTS; ENDOTHELIUM CELL; FAT INTAKE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; WISTAR RAT;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CATTLE; CAVEOLIN 1; CELLS, CULTURED; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; DIETARY FATS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GLUCOSE; MALE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES; SUCROSE;

EID: 84912550624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113716     Document Type: Article

References (45)

1. Nobe K, Miyatake M, Sone T, Honda K (2006) High-glucose-altered endothelial cell function involves both disruption of cell-to-cell connection and enhancement of force development. J Pharmacol Exp Ther 318: 530-539.
2. Onat D, Brillon D, Colombo PC, Schmidt AM (2011) Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis. Curr Diab Rep 11: 193-202.
3. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506.
4. Lin YL, Chang HC, Chen TL, Chang JH, Chiu WT, et al. (2010) Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J Nutr 140: 2187-2192.
5. Zhao LN, Yang ZH, Liu YH, Ying HQ, Zhang H, et al. (2011) Vascular endothelial growth factor increases permeability of the blood-tumor barrier via caveolae-mediated transcellular pathway. J Mol Neurosci 44: 122-129.
6. Kim YH, Kim YS, Roh GS, Choi WS, Cho GJ (2012) Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas. Acta Ophthalmol 90: e31-37.
7. Penumathsa SV, Thirunavukkarasu M, Zhan L, Maulik G, Menon VP, et al. (2008) Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J Cell Mol Med 12: 2350-2361.
8. Klinge CM, Wickramasinghe NS, Ivanova MM, Dougherty SM (2008) Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J 22: 2185-2197.
9. Sun SW, Zu XY, Tuo QH, Chen LX, Lei XY, et al. (2010) Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells. Acta Pharmacol Sin 31: 1336-1342.
10. Komarova Y, Malik AB (2010) Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 72: 463-493.
11. Maniatis NA, Kardara M, Hecimovich D, Letsiou E, Castellon M, et al. (2012) Role of caveolin-1 expression in the pathogenesis of pulmonary edema in ventilator-induced lung injury. Pulm Circ 2: 452-460.
12. Frank PG, Woodman SE, Park DS, Lisanti MP (2003) Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vac Biol 23: 1161-1168.
13. Lal BK, Varma S, Pappas PJ, Hobson RW 2nd, Duran WN (2001) VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvasc Res 62: 252-262.
14. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, et al. (2002) Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106: 1614-1617.
15. Rathel TR, Samtleben R, Vollmar AM, Dirsch VM (2007) Activation of endothelial nitric oxide synthase by red wine polyphenols: impact of grape cultivars, growing area and the vinification process. J Hypertens 25: 541-549.
16. Napoli R, Cozzolino D, Guardasole V, Angelini V, Zarra E, et al. (2005) Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. Metabolism 54: 306-313.
17. Yang HL, Chen WQ, Cao X, Worschech A, Du LF, et al. (2009) Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model. J Transl Med 7: 22.
18. Ying CJ, Xu JW, Ikeda K, Takahashi K, Nara Y, et al. (2003) Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II-induced hyperpermeability in endothelial cells. Hypertens Res 26: 823-828.
19. Rajesh M, Mukhopadhyay P, Batkai S, Hasko G, Liaudet L, et al. (2007) Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol-Heart C 293: H610-H619.
20. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, et al. (2003) Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem 278: 47281-47290.
21. Sanchez JBJ, Corral EC, DelgadoM JS, Orea JM, Urena AG (2005) Analysis of Trans-Resveratrol by Laser Ionization Mass Spectrometry and Hplc with Fluorescence Detection - Comparison between Both Techniques. Journal of Chromatography A1074: 133-138.
22. de Quiros ARB, Lopez-Hernandez J, Ferraces-Casais P, Lage-Yusty MA (2007) Analysis of Non- Anthocyanin Phenolic Compounds in Wine Samples Using High Performance Liquid Chromatography with Ultraviolet and Fluorescence Detection. Journal of Separation Science 30, 1262-1266.
23. Stoclet JC, Chataigneau T, Ndiaye M, Oak MH, El Bedoui J, et al. (2004) Vascular protection by dietary polyphenols. Eur J Pharmacol 500: 299-313.
24. Cho IJ, Ahn JY, Kim S, Choi MS, Ha TY (2008) Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters. Biochem Biophys Res Commun 367: 190-194.
25. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Sci 275: 218-220.
26. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS (2004) Resveratrol-associated renal toxicity. Toxicol Sci 82: 614-619.
27. Su HC, Hung LM, Chen JK (2006) Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 290: E1339-1346.
28. Breen DM, Sanli T, Giacca A, Tsiani E (2008) Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun 374: 117-122.
29. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122.
30. Williamson JR, Chang K, Tilton RG, Prater C, Jeffrey JR, et al. (1987) Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration. Diabetes 36: 813-821.
31. Arnal N, Tacconi de Alaniz MJ, Marra CA (2012) Natural polyphenols may ameliorate damage induced by copper overload. 50:415-422.
32. Hu P, Zhao L, Chen J (2014) Physiologically achievable doses of resveratrol enhance 3T3-L1 adipocyte differentiation. Eur J Nutr [Epub ahead of print]
33. Guo R, Li W, Liu B, Li S, Zhang B, et al. (2014) Resveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro. Med Sci Monit Basic Res20: 82-92.
34. Nosál' R, Drábiková K, Jančinová V, Perečko T, Ambrožová G, et al. (2014) On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes. Oxid Med Cell Longev 2014:706269.
35. Zhang P, Li H, Yang B, Yang F, Zhang LL, et al. (2014) Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells. Genes Cancer 5:154-164.
36. Schmitt CA, Dirsch VM (2009) Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide 21: 77-91.
37. Xu Q, Hao X, Yang Q, Si L (2009) Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase. Biochem Biophys Res Commun 388: 389-394.
38. Wang N, Ko SH, Chai W, Li G, Barrett EJ, et al. (2011) Resveratrol recruits rat muscle microvasculature via a nitric oxide-dependent mechanism that is blocked by TNFalpha. Am J Physiol Endocrinol Metab 300: E195-201.
39. Schubert W, Frank PG, Woodman SE, Hyogo H, Cohen DE, et al. (2002) Microvascular hyperpermeability in caveolin-1 (2/2) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J Biol Chem 277: 40091-40098.
40. Elcioglu KH, Kabasakal L, Cetinel S, Conturk G, Sezen SF, et al. (2010) Changes in caveolin-1 expression and vasoreactivity in the aorta and corpus cavernosum of fructose and streptozotocin-induced diabetic rats. Eur J Pharmacol 642: 113-120.
41. Tian C, Zhang R, Ye X, Zhang C, Jin X, et al. (2013) Resveratrol ameliorates high-glucose-induced hyperpermeability mediated by caveolae via VEGF/KDR pathway. Genes Nutr 8: 231-239.
42. Omar HA, Berman-Booty L, Weng JR (2012) Energy restriction: stepping stones towards cancer therapy. Future Oncol 8: 1503-1506.
43. Lin JN, Lin VC, Rau KM, Shieh PC, Kuo DH, et al. (2010) Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. J Agric Food Chem 58: 1584-1592.
44. Pallauf K, Giller K, Huebbe P, Rimbach G (2013) Nutrition and healthy ageing: calorie restriction or polyphenol-rich "MediterrAsian" diet? Oxid Med Cell Longev 2013: 707421.
45. Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86: 279-367.